MissionIR Articles

Located in Campbell, California, Rainmaker has quickly earned a reputation as a leading global provider of B2B e-commerce solutions that drive online sales and renewal for products, subscriptions and training for their clients. Today, Rainmaker…

Hydrogenics Corp. is a leading developer and manufacturer of hydrogen generation and fuel cell products. The Canadian-based firm has operations in North America and Europe, serving the growing industrial and clean energy markets. The company…

U.S. Treasury securities have traditionally been considered the safest investments in the world. They are, after all, backed by the “full faith and credit” of the U.S. federal government, a safety net unmatched by any…

Accuray Inc. yesterday announced that it has surpassed 600 installations of its CyberKnife Robotic Radiosurgery System and TomoTherapy System globally. The numbers were presented at the 30th annual J.P. Morgan Healthcare Conference in San Francisco…

China, the world’s second largest economy, saw a decline in both imports and exports between October and December with a GDP growth of 8.7 percent, which is down a full percentage point from the first…

China Shen Zhou Mining & Resources announced Monday the signing of a Memorandum of Understanding calling for the merger and acquisition of several fluorite and barite mining and processing companies in the Guizhou province of…

NeoGenomics Inc., a leading provider of cancer-focused genetic testing services, today announced that it has licensed the exclusive worldwide rights to use Health Discovery Corp.’s (HDC) intellectual property portfolio to develop laboratory developed tests (LDTs)…

U.S. Treasury securities have traditionally been considered the safest investments in the world. They are, after all, backed by the “full faith and credit” of the U.S. federal government, a safety net unmatched by any…

Jamba, Inc. issued a business report on the company’s activities in the United States, including updated financial and operational data. Jamba confirmed that the company’s growth in same store sales for fiscal 2011 will be…

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China. Its product portfolio, of nearly 20 drugs sold in over 30 countries, includes therapies for oncology, infectious diseases, and cardiovascular,…

NEI, a leading provider of server-based application platforms, deployment solutions and lifecycle support services for software technology developers and OEMs worldwide, recently announced revised and improved expectations for the first fiscal quarter period ending December…

Yesterday, A123 Systems announced that they would be supplying complete lithium ion battery packs to VIA Motors for use in VIA’s eREV Powertrain vehicles. The 24kWh batteries will power both an onboard motor and generator…

ESP Resources Inc., an oil and gas services company offering analytical services and essential custom-blended oil and gas well chemicals to improve production yields and overall efficiencies, today announced the deployment of its sixth chemical…

BioDelivery Sciences International, a specialty pharmaceutical company focused on developing products in the areas of pain management and oncology supportive care, today announced it has signed a $180 million agreement with Endo Pharmaceuticals for worldwide…

Albany Molecular Research Inc., an Albany based global contract services and manufacturing organization, announced today that it will work with BioPontis Alliance, LLC in a preferred provider agreement to support BioPontis’ mission to bridge the…

Targacept, Inc. currently has five mid-to-late-stage drug candidates using innovative NNR Therapeutics for difficult to treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulates the activity of specific neuronal nicotinic receptors, which…

In recent news, Car Charging Group told investors that it has secured a partnership with Federal Realty Investment Trust (NYSE: FRT), a $5.6 billion dollar equity real estate investment trust specializing in the ownership, management…

Clinical stage biopharmaceutical company Athersys Inc. today announced it has been granted a patent that covers the company’s proprietary cell therapy product, MultiStem®. MultiStem is an investigational stem cell therapy with demonstrated therapeutic potential to…

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities (NMEs), today announced it has completed the expanded patient enrollment phase of its Ampion™ In Knee…

We hope all our readers had a wonderful holiday season. As you know, the stock market was closed a couple days in observation of Christmas and New Year’s Day. Let’s take a look at other…

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced earlier today that it has executed a five year, $15 million debt…

ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, has been awarded a patent from the U.S. Patent and Trademark Office (USPTO) for the company’s methods of treating patients with bucindolol…

JA Solar Holdings Co. Ltd, one of the world’s largest manufacturers of high-performance solar cells and solar power products, today announced an exclusive deal with Solarhybrid AG (SHL) a Germany-based project developer and general contractor…

Kratos, continues to gain dominance in the field of highly specialized national security technology and providing a complete mission critical products/services envelope, reporting today successful nomination for two separate, influential awards in IT and middle…

Today, Onyx Service & Solutions announced that it has developed a plan to successfully distribute power on its new 22-megawatt project in Roatan, Honduras. With problems arising from an older distribution system, the plan will…

Miami-based IVAX Diagnostics, an in-vitro diagnostics company, has entered into an amendment to an April 8, 2011, agreement with ERBA Diagnostics Mannheim GmbH, in which IVAX agreed to sell to ERBA 20 million shares of…

Peregrine Pharmaceuticals Inc., a biopharmaceutical company focused on developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today issued an update on its randomized phase II bavituximab study in patients infected with…